{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:44:24Z","timestamp":1767872664746,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Rostock"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a paucity of information regarding the results of patients with uveitis and secondary epiretinal membrane (sERM) who undergo pars plana vitrectomy and membrane peeling. This study aims to analyse the functional and anatomical outcomes and possible prognostic factors of a large cohort of eyes with uveitis-associated sERM who underwent vitrectomy with epiretinal membrane peeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The results of 76 eyes of 76 consecutive patients with uveitis-associated sERM who underwent pars plana vitrectomy with membrane peeling were analysed. The mean follow-up duration was 42.7 \u00b1 47.9 months. Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) before and after intervention were measured. Furthermore, demographic data, type of uveitis according to the Standardization of Uveitis Nomenclature (SUN) classification, benefit of additional peeling of the Membrana limitans interna (ILM), activity status of the uveitis at the time of surgery, lens status and postoperative complications were evaluated. Statistical tests included paired t tests, Wilcoxon signed-rank tests, Mann\u2012Whitney tests, and Kruskal\u2012Wallis H tests. Statistical significance was defined as p &lt; 0.05; Holm\u2012Bonferroni correction was employed to address the cumulative risk of false-positive outcomes (type I error).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CRT improved from 421.2 \u00b1 133.2 \u00b5m prior to surgery to 331.7\u00b1142.5 \u00b5m at the final follow-up (p = 0.069), whereas BCVA deteriorated from a mean of 0.49 \u00b1 0.30 logMAR to 0.56 \u00b1 0.60 logMAR in the overall cohort (p &gt; 0.99). The rate of concomitant cystoid macular edema decreased from 42.4% to 34.3%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The indications for membrane peeling in patients with a secondary epiretinal membrane and uveitis should be considered carefully. Anatomical features can be positively influenced by pars plana vitrectomy with ERM peeling, whereas BCVA may only result in beneficial changes in carefully selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00773-3","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:16:56Z","timestamp":1765253816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peeling of secondary epiretinal membrane in uveitis\u2013functional improvement to be expected?"],"prefix":"10.1186","volume":"12","author":[{"given":"Julia","family":"Schirrwagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Sch\u00f6neberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Fuchsluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","first-page":"1121270","DOI":"10.3389\/fmed.2023.1121270","volume":"10","author":"MK O\u017c\u00f3g","year":"2023","unstructured":"O\u017c\u00f3g MK, Nowak-W\u0105s M, Rokicki W. Pathophysiology and clinical aspects of epiretinal membrane - review. Front Med (Lausanne). 2023;10:1121270.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"773_CR2","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.ophtha.2014.06.015","volume":"121","author":"BP Nicholson","year":"2014","unstructured":"Nicholson BP, Zhou M, Rostamizadeh M, Mehta P, Agr\u00f3n E, Wong W, et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121(12):2393\u201398.","journal-title":"Ophthalmology"},{"issue":"11","key":"773_CR3","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/IAE.0000000000003572","volume":"42","author":"T Felfeli","year":"2022","unstructured":"Felfeli T, Eshtiaghi A, Tai F, Batawi H, Rhee J, Kryshtalskyj M, et al. Optical coherence tomography features in idiopathic noninfectious intermediate, posterior, or PANUVEITIS. Retina. 2022;42(11):2143\u201349.","journal-title":"Retina"},{"issue":"1","key":"773_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ceo.14338","volume":"52","author":"A Yap","year":"2024","unstructured":"Yap A, Lu LM, Sims JL, Welch S, Niederer RL. Epiretinal membrane in uveitis: rate, visual prognosis, complications and surgical outcomes. Clin Exp Ophthalmol. 2024;52(1):54\u201362.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"773_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","volume":"149","author":"JH Kempen","year":"2010","unstructured":"Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149(4):550\u201361.e10.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"773_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10792-024-03199-2","volume":"44","author":"D Kalogeropoulos","year":"2024","unstructured":"Kalogeropoulos D, Lotery AJ, Gupta B, Lash S, Antonakis S. Epiretinal membranes in patients with uveitis: an update on the current state of management. Int Ophthalmol. 2024;44(1):291.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"773_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","volume":"106","author":"SC Raja","year":"1999","unstructured":"Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, et al. Pars planitis: clinical features and class ii HLA associations. Ophthalmology. 1999;106(3):594\u201399.","journal-title":"Ophthalmology"},{"issue":"12","key":"773_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1097\/IAE.0000000000000349","volume":"34","author":"S-C Bu","year":"2014","unstructured":"Bu S-C, Kuijer R, Li X-R, Hooymans JMM, Los LI. Idiopathic epiretinal membrane. Retina. 2014;34(12):2317\u201335.","journal-title":"Retina"},{"key":"773_CR9","first-page":"1794","volume":"17","author":"SYL Oberstein","year":"2011","unstructured":"Oberstein SYL, Byun J, Herrera D, Chapin EA, Fisher SK, Lewis GP. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis. 2011;17:1794\u2013805.","journal-title":"Mol Vis"},{"issue":"3","key":"773_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ceo.13914","volume":"49","author":"AT Fung","year":"2021","unstructured":"Fung AT, Galvin J, Tran T. Epiretinal membrane: A review. Clin Exp Ophthalmol. 2021;49(3):289\u2013308.","journal-title":"Clin Exp Ophthalmol"},{"issue":"12","key":"773_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1136\/bjophthalmol-2019-315432","volume":"104","author":"JP Hubschman","year":"2020","unstructured":"Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS, et al. Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol. 2020;104(12):1741\u201347.","journal-title":"Br J Ophthalmol"},{"key":"773_CR12","volume-title":"StatPearls: Epiretinal Membrane","author":"VM Kanukollu","year":"2025","unstructured":"Kanukollu VM, Agarwal P. StatPearls: Epiretinal Membrane. Treasure Island (FL); 2025"},{"issue":"4","key":"773_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332\u201336.","journal-title":"Br J Ophthalmol"},{"key":"773_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.12.006","volume":"175","author":"A Govetto","year":"2017","unstructured":"Govetto A, Lalane RA, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a New optical coherence tomography staging scheme. Am J Ophthalmol. 2017;175:99\u2013113.","journal-title":"Am J Ophthalmol"},{"key":"773_CR15","doi-asserted-by":"crossref","unstructured":"Cristescu I-E, Ivanova T, Moussa G, Ferrara M, Patton N, Dhawahir-Scala F, et al. Functional and anatomical outcomes of pars Plana Vitrectomy for Epiretinal membrane in patients with uveitis. Diagn (Basel). 2022;12(12).","DOI":"10.3390\/diagnostics12123044"},{"key":"773_CR16","doi-asserted-by":"crossref","unstructured":"Coassin M, Mori T, Mastrofilippo V, Sborgia G, de MM, Carl\u00e0 MM, et al. Surgical management of post-uveitic epiretinal membranes. Eur J Ophthalmol. 2021;11206721211017750.","DOI":"10.1177\/11206721211017750"},{"issue":"4","key":"773_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/IAE.0000000000000378","volume":"35","author":"RG Tanawade","year":"2015","unstructured":"Tanawade RG, Tsierkezou L, Bindra MS, Patton NA, Jones NP. Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis. Retina. 2015;35(4):736\u201341.","journal-title":"Retina"},{"issue":"3","key":"773_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.oret.2017.07.002","volume":"2","author":"P Rao","year":"2018","unstructured":"Rao P, Todorich B, Yonekawa Y, Wang J, Sobrin L, Faia LJ. Surgical outcomes of epiretinal membranes in patients with a history of well-controlled preoperative uveitis. Ophthalmol Retina. 2018;2(3):192\u201396.","journal-title":"Ophthalmol Retina"},{"key":"773_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajo.2021.04.028","volume":"231","author":"PM Far","year":"2021","unstructured":"Far PM, Yeung SC, Ma PE, Hurley B, Kertes P, You Y, et al. Effects of internal limiting membrane peel for idiopathic epiretinal membrane surgery: a systematic review of randomized controlled trials. Am J Ophthalmol. 2021;231:79\u201387.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"773_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10384-009-0778-0","volume":"54","author":"JW Lee","year":"2010","unstructured":"Lee JW, Kim IT. Outcomes of idiopathic macular epiretinal membrane removal with and without internal limiting membrane peeling: a comparative study. Jpn J Ophthalmol. 2010;54(2):129\u201334.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"773_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"773_CR22","unstructured":"[Der Titel \u201cHemmerich 2016 - StatistikGuru\u201d kann nicht dargestellt werden. Die Vorlage \u201cLiteraturverzeichnis - Zeitschriftenaufsatz -(Standardvorlage)\u201d beinhaltet nur Felder, welche bei diesem Titel leer sind.]"},{"issue":"6","key":"773_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S0161-6420(99)90247-6","volume":"106","author":"S Dev","year":"1999","unstructured":"Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106(6):1086\u201390.","journal-title":"Ophthalmology"},{"issue":"1","key":"773_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0161-6420(02)01440-9","volume":"110","author":"DW Park","year":"2003","unstructured":"Park DW, Dugel PU, Garda J, Sipperley JO, Thach A, Sneed SR, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003;110(1):62\u201364.","journal-title":"Ophthalmology"},{"key":"773_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajo.2018.03.031","volume":"190","author":"CR Henry","year":"2018","unstructured":"Henry CR, Becker MD, Yang Y, Davis JL. Pars plana vitrectomy for the treatment of uveitis. Am J Ophthalmol. 2018;190:142\u201349.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"773_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00417-022-05862-9","volume":"261","author":"J-H Hung","year":"2023","unstructured":"Hung J-H, Rao NA, Chiu W-C, Sheu S-J. Vitreoretinal surgery in the management of infectious and non-infectious uveitis - a narrative review. Graefes Arch Clin Exp Ophthalmol. 2023;261(4):913\u201323.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"773_CR27","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.4103\/ijo.IJO_1625_20","volume":"68","author":"R Bansal","year":"2020","unstructured":"Bansal R, Dogra M, Chawla R, Kumar A. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery. Indian J Ophthalmol. 2020;68(9):1844\u201351.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"773_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ajo.2005.07.017","volume":"140","author":"M Becker","year":"2005","unstructured":"Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140(6):1096\u2013105.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"773_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/09273948.2019.1569243","volume":"27","author":"MO Tallouzi","year":"2019","unstructured":"Tallouzi MO, Moore DJ, Barry RJ, Calvert M, Mathers J, Murray PI, et al. The effectiveness of pharmacological agents for the treatment of uveitic macular edema (UMO): a systematic review. Ocul Immunol Inflamm. 2019;27(4):658\u201380.","journal-title":"Ocul Immunol Inflamm"},{"key":"773_CR30","unstructured":"[Der Titel \u201cRomano, Angi, et al - Inflammation and macular oedema\u201d kann nicht dargestellt werden. Die Vorlage \u201cLiteraturverzeichnis - Zeitschriftenaufsatz - 2013. (Standardvorlage)\u201d beinhaltet nur Felder, welche bei diesem Titel leer sind.]"},{"key":"773_CR31","unstructured":"[Der Titel \u201cTomkins-Netzer, Talat, et al - Long-term clinical outcome and causes\u201d kann nicht dargestellt werden. Die Vorlage \u201cLiteraturverzeichnis - Zeitschriftenaufsatz - 2014. (Standardvorlage)\u201d beinhaltet nur Felder, welche bei diesem Titel leer sind.]"},{"issue":"6","key":"773_CR32","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S0161-6420(01)00558-9","volume":"108","author":"J Kiryu","year":"2001","unstructured":"Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108(6):1140\u201344.","journal-title":"Ophthalmology"},{"issue":"6","key":"773_CR33","doi-asserted-by":"publisher","first-page":"e0179105","DOI":"10.1371\/journal.pone.0179105","volume":"12","author":"W-C Chang","year":"2017","unstructured":"Chang W-C, Lin C, Lee C-H, Sung T-L, Tung T-H, Liu J-H. Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: a meta-analysis. PLoS One. 2017;12(6):e0179105.","journal-title":"PLoS One"},{"issue":"5","key":"773_CR34","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1167\/iovs.15-16837","volume":"56","author":"G Jakobsson","year":"2015","unstructured":"Jakobsson G, Sundelin K, Zetterberg H, Zetterberg M. Increased levels of inflammatory immune mediators in vitreous from pseudophakic eyes. Invest Ophthalmol Vis Sci. 2015;56(5):3407\u201314.","journal-title":"Invest. Ophthalmol. Vis. Sci"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00773-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:16:04Z","timestamp":1767856564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-025-00773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00773-3","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Rostock University Medical Center (protocol code A 2022\u20130124 and date of approval). Patient consent was waived due to the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the study was a retrospective analysis, waiver for informed consent was obtained from the IRB of the institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflicting relationship exists for any author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}